Reuters logo
BRIEF-Circassia Pharmaceuticals fy revenues increased to 23.1 mln stg
April 25, 2017 / 6:36 AM / 8 months ago

BRIEF-Circassia Pharmaceuticals fy revenues increased to 23.1 mln stg

April 25 (Reuters) - Circassia Pharmaceuticals Plc :

* Preliminary results for year ended 31 December 2016

* FY revenues increased to £23.1 million (2015: £10.8 million)

* FY research and development investment £46.2 million (2015: £46.8 million) including allergy expenditure of £21.5 million

* FY underlying loss for year £57.4 million (2015: £50.0 million); total loss £137.4 million (2015: £50.0 million)

* Fy allergy portfolio provisions, restructuring costs and impairments £80.0 million 4 (2015: £nil)

* Strong balance sheet with £117.4 million cash 5 at 31 december 2016 (31 december 2015: £203.8 million with £33.2 million relating to 2015 acquisitions paid during 2016) Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below